Back

he why and the how of cardiovascular risk management with SGLT2 inhibitors in the primary care setting: a tutorial for general practitioners

30 August 2025 (17:15 - 18:00)
Organised by: Logo
Congress Presentation Part of: The why and the how of cardiovascular risk management with SGLT2 inhibitors in the primary care setting: a tutorial for general practitioners Cardiovascular Disease in Primary Care ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Professor Ana Cebrian

General University Hospital Santa Lucia, Cartagena (Spain)

Access the full session

Session thumbnail
The why and the how of cardiovascular risk management with SGLT2 inhibitors in the primary care setting: a tutorial for general practitioners

The Event

Event poster

ESC Congress 2025

30 August 2025 17:15 CET
You may be interested in
thumbnail
Congress Session
Practical guidance to implement heart failure treatment with SGLT2 inhibitors in the outpatient setting
27 August 2023
thumbnail
Congress Presentation
Cardiovascular benefits of SGLT2i in type 2 diabetes without heart failure: a subgroup analysis
30 August 2025
thumbnail
Congress Presentation
SGLT2i uptake among heart failure patients with reduced ejection fraction: ongoing prescriber hesitancy and how to address this.
29 August 2022
thumbnail
Congress Session
Cardiovascular risk management in primary care: a breakthrough for patients - Tutorials for primary care physicians and professionals
30 August 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources